R
Robert M. Henshaw
Researcher at MedStar Washington Hospital Center
Publications - 43
Citations - 2691
Robert M. Henshaw is an academic researcher from MedStar Washington Hospital Center. The author has contributed to research in topics: Denosumab & Femur. The author has an hindex of 17, co-authored 39 publications receiving 2303 citations. Previous affiliations of Robert M. Henshaw include Washington Cancer Institute & Georgetown University.
Papers
More filters
Journal ArticleDOI
Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
David Thomas,Robert M. Henshaw,Keith M. Skubitz,Sant P. Chawla,Arthur P. Staddon,Jean-Yves Blay,Martine Roudier,Judy Smith,Zhishen Ye,Winnie Sohn,Roger Dansey,Susie Jun +11 more
TL;DR: In this article, the potential therapeutic effect of denosumab, a fully human monoclonal antibody against RANKL, on tumour-cell survival and growth in patients with GCT was investigated.
Journal ArticleDOI
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study.
Sant P. Chawla,Robert M. Henshaw,Leanne L. Seeger,Edwin Choy,Jean-Yves Blay,Stefano Ferrari,Judith R. Kroep,Robert J. Grimer,Peter Reichardt,Piotr Rutkowski,Scott M. Schuetze,Keith M. Skubitz,Arthur P. Staddon,David Thomas,Yi Qian,Ira Jacobs +15 more
TL;DR: Denosumab was associated with tumour responses and reduced the need for morbid surgery in patients with GCTB and represents a new treatment option for patients with the rare giant cell tumour of bone.
Journal ArticleDOI
Cryosurgery in the treatment of giant cell tumor. A long-term followup study.
Martin M. Malawer,Jacob Bickels,Isaac Meller,Richard G. Buch,Robert M. Henshaw,Yehuda Kollender +5 more
TL;DR: Cryosurgery has the advantages of joint preservation, excellent functional outcome, and low recurrence rate when compared with other joint preservation procedures, and it is recommended as an adjuvant to curettage for most giant cell tumors of bone.
Journal ArticleDOI
The percutaneous needle biopsy is safe and recommended in the diagnosis of musculoskeletal masses: Outcomes analysis of 155 patients at a sarcoma referral center
TL;DR: The purpose of this study was to analyze the role of percutaneous core needle biopsy in the diagnosis of musculoskeletal sarcomas.
Journal ArticleDOI
Diagnosis of primary bone tumors with image-guided percutaneous biopsy: Experience with 110 tumors
James S. Jelinek,Mark D. Murphey,James A. Welker,Robert M. Henshaw,Mark J. Kransdorf,Barry M. Shmookler,Martin M. Malawer +6 more
TL;DR: Percutaneous biopsy of primary bone tumors is safe and accurate for diagnosis and grade of specific tumor, in cases with nondiagnostic biopsy.